Considering the limitations of the scRNA-seq data, we analyzed tissue samples of patients with FSGS and also observed an upregulation of Gpr126 expression in PECs in humans, which was limited to the PECs inside glomerular lesions. This evidence concerns the gene ADGRG6 and focal segmental glomerulosclerosis.